Pilar Martı́nez

1.4k total citations
23 papers, 638 citations indexed

About

Pilar Martı́nez is a scholar working on Hematology, Public Health, Environmental and Occupational Health and Genetics. According to data from OpenAlex, Pilar Martı́nez has authored 23 papers receiving a total of 638 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Hematology, 6 papers in Public Health, Environmental and Occupational Health and 5 papers in Genetics. Recurrent topics in Pilar Martı́nez's work include Acute Lymphoblastic Leukemia research (6 papers), Chronic Myeloid Leukemia Treatments (5 papers) and Chronic Lymphocytic Leukemia Research (4 papers). Pilar Martı́nez is often cited by papers focused on Acute Lymphoblastic Leukemia research (6 papers), Chronic Myeloid Leukemia Treatments (5 papers) and Chronic Lymphocytic Leukemia Research (4 papers). Pilar Martı́nez collaborates with scholars based in Spain, United States and United Kingdom. Pilar Martı́nez's co-authors include Estella Matutes, Gareth J. Morgan, Rachel Wade, Claire Dearden, David Oscier, Sue Richards, Daniel Catovsky, David González, Sarah L. Hockley and Josep‐María Ribera and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Gastroenterology.

In The Last Decade

Pilar Martı́nez

22 papers receiving 618 citations

Peers

Pilar Martı́nez
Katie Seo United States
R Morgan United States
Annet Simons Netherlands
MJ Brisco Australia
Pilar Martı́nez
Citations per year, relative to Pilar Martı́nez Pilar Martı́nez (= 1×) peers Rieko Kubo

Countries citing papers authored by Pilar Martı́nez

Since Specialization
Citations

This map shows the geographic impact of Pilar Martı́nez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pilar Martı́nez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pilar Martı́nez more than expected).

Fields of papers citing papers by Pilar Martı́nez

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pilar Martı́nez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pilar Martı́nez. The network helps show where Pilar Martı́nez may publish in the future.

Co-authorship network of co-authors of Pilar Martı́nez

This figure shows the co-authorship network connecting the top 25 collaborators of Pilar Martı́nez. A scholar is included among the top collaborators of Pilar Martı́nez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pilar Martı́nez. Pilar Martı́nez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ribera, Josep‐María, Mireia Morgades, Pau Montesinos, et al.. (2024). Ponalfil trial for adults with Philadelphia chromosome‐positive acute lymphoblastic leukemia: Long‐term results. HemaSphere. 8(4). e67–e67. 10 indexed citations
3.
Ramos, Fernando, Pilar Martı́nez, Manuel Barrios, et al.. (2023). Survival Outcomes and Health-Related Quality of Life in Older Adults Diagnosed with Acute Myeloid Leukemia Receiving Frontline Therapy in Daily Practice. Journal of Personalized Medicine. 13(12). 1667–1667. 1 indexed citations
4.
Ribera, Josep‐María, Jordi Ribera, Pau Montesinos, et al.. (2022). Ponatinib, chemotherapy, and transplant in adults with Philadelphia chromosome–positive acute lymphoblastic leukemia. Blood Advances. 6(18). 5395–5402. 37 indexed citations
5.
Martı́nez, Pilar, et al.. (2021). 4CPS-287 Impact of SARS-CoV-2 infection in acute myeloid leukaemia patients: experience of the Pethema registry. Section 4: Clinical pharmacy services. A58.2–A59. 2 indexed citations
6.
Ribera, Josep‐María, Olga García, Jordi Ribera, et al.. (2021). Ponatinib and Chemotherapy in Adults with De Novo Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia. Final Results of Ponalfil Clinical Trial. Blood. 138(Supplement 1). 1230–1230. 4 indexed citations
7.
Ribera, Josep‐María, Olga García, Pau Montesinos, et al.. (2020). Ponatinib and Chemotherapy in Young Adults with De Novo Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia. Results of Ponalfil Clinical Trial after Completion of Recruitment. Blood. 136(Supplement 1). 29–30. 1 indexed citations
8.
Salgado, Carmen, et al.. (2016). Results of Therapy for Wilms Tumor and Other Malignant Kidney Tumors: A Report From the Chilean Pediatric National Cancer Program (PINDA). Journal of Pediatric Hematology/Oncology. 38(5). 372–377. 6 indexed citations
9.
Martín‐Martín, Lourdes, Antonio López, María‐Belén Vídriales, et al.. (2015). Classification and clinical behavior of blastic plasmacytoid dendritic cell neoplasms according to their maturation-associated immunophenotypic profile. Oncotarget. 6(22). 19204–19216. 71 indexed citations
10.
González, David, Pilar Martı́nez, Rachel Wade, et al.. (2011). Mutational Status of the TP53 Gene As a Predictor of Response and Survival in Patients With Chronic Lymphocytic Leukemia: Results From the LRF CLL4 Trial. Journal of Clinical Oncology. 29(16). 2223–2229. 179 indexed citations
11.
Meije, Yolanda, Manuel Lizasoaín, Ana García‐Reyne, et al.. (2010). Emergence of Cytomegalovirus Disease in Patients Receiving Temozolomide: Report of Two Cases and Literature Review. Clinical Infectious Diseases. 50(12). e73–e76. 20 indexed citations
12.
Fortea, José Ignacio, Yago González‐Lama, María Chaparro, et al.. (2010). W1313 Adalimumab for Luminal and Perianal Crohn's Disease in Real Practice: A Long-Term Multicenter Study of Effectiveness, Safety and Predictors of Response. Gastroenterology. 138(5). S–697. 1 indexed citations
13.
Martı́nez, Pilar, et al.. (2008). Preemptive Therapy for Cytomegalovirus Disease in Allogeneic Stem Cell Transplant Recipients. Transplantation Proceedings. 40(9). 3102–3103. 4 indexed citations
14.
González, David, Pilar Martı́nez, Rachel Wade, et al.. (2008). Mutational Status of the TP53 Gene as a Predictor of Response and Survival in CLL Patients with and without 17p Deletion. Blood. 112(11). 784–784. 6 indexed citations
15.
Renshaw, Andrew A., Robert P. Derhagopian, Pilar Martı́nez, & Edwin W. Gould. (2006). Lobular Neoplasia in Breast Core Needle Biopsy Specimens Is Associated With a Low Risk of Ductal Carcinoma in Situ or Invasive Carcinoma on Subsequent Excision. American Journal of Clinical Pathology. 126(2). 310–313. 1 indexed citations
16.
Ferrer, Miquel, Pilar Martı́nez, & Antoni Torres. (2006). Intermediate Respiratory Care Units. Clinical Pulmonary Medicine. 13(5). 289–295. 1 indexed citations
17.
Alonso, Antonio, Pablo Martı́n, Cristina Albarrán, et al.. (2005). Challenges of DNA profiling in mass disaster investigations.. PubMed. 46(4). 540–8. 122 indexed citations
18.
Valenzuela, Pedro L., et al.. (2001). Comparison of cervical smears secured with different instruments. Acta Obstetricia Et Gynecologica Scandinavica. 80(3). 262–266. 5 indexed citations
19.
Valenzuela, Pedro L., et al.. (2001). Comparison of cervical smears secured with different instruments. Acta Obstetricia Et Gynecologica Scandinavica. 80(3). 262–262. 1 indexed citations
20.
Martı́nez, Pilar, et al.. (1999). Kikuchi's Disease With Multisystemic Involvement and Adverse Reaction to Drugs. PEDIATRICS. 104(2). e24–e24. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026